Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease

EF Balcom, A Nath, C Power - Brain, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …

[HTML][HTML] Neurological sequelae of COVID-19

SJ Ahmad, CM Feigen, JP Vazquez… - Journal of integrative …, 2022 - imrpress.com
Background: Though primarily a pulmonary disease, Coronavirus disease 2019 (COVID-19)
caused by the SARS-CoV-2 virus can generate devastating disease states that affect …

Frequency of neurological diseases after COVID-19, influenza A/B and bacterial pneumonia

P Zarifkar, C Peinkhofer, ME Benros… - Frontiers in …, 2022 - frontiersin.org
Introduction COVID-19 might affect the incidence of specific neurological diseases, but it is
unknown if this differs from the risk following other infections. Here, we characterized the …

Neurological consequences of COVID-19

W Brola, M Wilski - Pharmacological Reports, 2022 - Springer
In December 2019, cases of pneumonia caused by infection with the previously unknown
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to coronavirus …

[HTML][HTML] The relationship between COVID-19 infection and intracranial hemorrhage: a systematic review

SR Daly, AV Nguyen, Y Zhang, D Feng, JH Huang - Brain Hemorrhages, 2021 - Elsevier
Introduction In addition to the deleterious effects Covid-19 has on the pulmonary and
cardiovascular systems, COVID-19 can also result in damage to the nervous system. This …

Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up

S COVID - Journal of Neurology, Neurosurgery & Psychiatry, 2022 - jnnp.bmj.com
Background Prior studies indicated a decrease in the incidences of aneurysmal
subarachnoid haemorrhage (aSAH) during the early stages of the COVID-19 pandemic. We …

Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up

TN Nguyen, M Roje Bedekovic… - Journal of Neurology …, 2022 - repozitorij.kbcsm.hr
Background: Prior studies indicated a decrease in the incidences of aneurysmal
subarachnoid haemorrhage (aSAH) during the early stages of the COVID-19 pandemic. We …

Acute neurologic complications of COVID-19 and postacute sequelae of COVID-19

NS Dangayach, V Newcombe… - Critical Care …, 2022 - criticalcare.theclinics.com
Neurologic complications of COVID-19 are common. They can occur in patients with mild to
severe COVID-19. Cerebrovascular complications, such as acute ischemic stroke, are seen …

[HTML][HTML] The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic

GJ Kontoghiorghes, S Fetta… - Frontiers in Bioscience …, 2021 - imrpress.com
Thousands of drugs, nutraceuticals and their combinations can be used to select candidate
therapeutics for targeting SARS-CoV-2 and its symptoms in order to curb COVID-19. A …

Impact of COVID-19 pandemic on acute stroke care in a tertiary stroke centre

M Héja, I Fekete, S Márton, L Horváth, K Fekete - Scientific Reports, 2024 - nature.com
The aim of this study was to evaluate how COVID-19 affected acute stroke care and outcome
in patients with acute ischemic or hemorrhagic stroke. We performed a retrospective …